Modeling-based assessment of exposure measurements after high-dose targeted (131)I-apamistamab: Results and analyses from the phase III SIERRA trial Meeting Abstract


Authors: Pandit-Taskar, N.; Chen, L.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
Abstract Title: Modeling-based assessment of exposure measurements after high-dose targeted (131)I-apamistamab: Results and analyses from the phase III SIERRA trial
Meeting Title: 2024 Annual Congress of the European Association of Nuclear Medicine (EANM'24)
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 51
Issue: Suppl. 1
Meeting Dates: 2024 Oct 19-23
Meeting Location: Hamburg, Germany
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2024-12-01
Start Page: S45
Language: English
ACCESSION: WOS:001332779400086
PROVIDER: wos
DOI: 10.1007/s00259-024-06838-z
Notes: Meeting Abstract: OP-097 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors